background

Global left atrial appendage occlusion summit

Cardialysis is the proud organizer of this yearly event

Left Atrial Appendage Occlusion therapy has become an established and increasingly popular alternative therapy for the prevention of AF-related stroke.


Clinical research initiatives continue to show the therapeutic opportunities and benefits of this potential lifesaving therapy. Worldwide adoption is increasing, more implanters are using devices and new clinical trials are in progress to further build the base of clinical evidence.


Stroke neurologists, gastroenterologists and other referring medical specialist have started to refer patients to implanting cardiologists. Patient selection and patient eligibility are returning questions for the physician community which require discussion among experts from the field of cardiology, neurology and other key non-implanting specialties. 


The objective of this annual meeting is to share ideas, thoughts and exchange experiences among experienced LAA occlusion devices and experts in the field of stroke prevention. It is designed to go beyond
discussing the current available clinical data and aims to address new developments.

Scientific session:

This Global 7th meeting focuses on stroke prevention in general and the role of left atrial appendage occlusion, pre- & intra-procedural imaging during left atrial appendage occlusion and follow-up strategies, patient selection and patient referral for left atrial appendage occlusion and tips & tricks ensuring success and avoiding adverse events during a meet-the-expert session.

PROGRAMME OUTLINE

  1.  Stroke prevention and the role of LAA occlusion

Review and update on stroke risk and prevention, patient and indications, new developments in devices and clinical evidence.

  1. Key steps before, during and after the procedure

Imaging the LAA for implantation, the anatomical differences, the role of imaging techniques. What to do after the procedure? Which pharma-cological therapy?

  1. Patient selection and ensuring procedure success

Which patients would benefit from LAA occlusion therapy? Expert discussions about going beyond the obvious patent populations.

  1. Future of hybrid procedures
    Which patients would benefit from LAA occlusion therapy? Expert discussions about going beyond the obvious patent populations.

  2. Meet-the-expert to discuss and share tips & tricks for successful implantation


Accreditation

This activity has been planned and implemented in accordance with the essential areas and policies of The European Board for Accreditation in Cardiology (EBAC).

For more information, you can visit www.laaocclusion.org

Left Atrial Appendage Occlusion Summit 2016
Left Atrial Appendage Occlusion Summit 2015
Left Atrial Appendage Occlusion Summit 2014
Left Atrial Appendage Occlusion Summit 2013
Left Atrial Appendage Occlusion Summit 2012